Reviva Pharmaceuticals Holdings (RVPH) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
RVPH is expected to report earnings to fall 7.32% to -23 cents per share on March 24
Q4'24
Est.
$-0.23
Q3'24
Est.
$-0.25
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.13
Q4'23
Missed
by $0.03
The last earnings report on November 14 showed earnings per share of -25 cents, missing the estimate of -24 cents. With 333.63K shares outstanding, the current market capitalization sits at 40.46M.
a blank check company, which focuses on the merger, capital stock exchange, asset acquisition, stock purchase, reorganization, recapitalization, and exchangeable share transaction.